Cigna Group (The)

The Cigna Group delivered a standout first quarter for 2025, posting earnings per share of $6.74 against a consensus estimate of $6.35, a beat of 6.17%, while revenue of $65.50 billion cleared expectations by 8.48% and grew 14.4% year-over-year. The primary engine behind that top-line surge was Evernorth Health Services, where specialty pharmacy momentum and expanding client relationships drove adjusted revenues 16% higher, with specialty and care services alone climbing 19% on strong biosimilar adoption. Cigna also completed the divestiture of its Medicare businesses to Health Care Services Corporation in March, a transaction that reshaped the portfolio and contributed to a higher medical care ratio of 82.2%, though management views the underlying commercial business as fundamentally sound. The strong results arrive at a telling moment for the sector, as peers have struggled with elevated medical costs, lending Cigna's performance added significance. Reflecting that confidence, the company raised its full-year 2025 adjusted income outlook to at least $29.60 per share, up $0.10 from prior guidance.